SEC Form 4 · accession 0001140361-15-028638
ANGIODYNAMICS INC · ANGO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Stark Richard
Officer — SVP, GM - Oncology
Period of report
Jul 22, 2015
Accepted (ET)
Jul 24, 2015 · 9:30 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001275187
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jul 22, 2015 | A | 4,287 | $0.00 | A | 32,988 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy)F2 | $15.95 | Jul 22, 2015 | A | 14,704 | A | Jul 22, 2016 | Jul 22, 2022 | Common Stock | 14,704 | 14,704 | D |
| Performance RightF3 | — | Jul 22, 2015 | A | 5,716 | A | — | — | Common Stock | 5,716 | 5,716 | D |
Explanation of responses
- F1This acquisition of 4,287 shares of common stock ("Common Stock") of AngioDynamics, Inc. (the "Company"), represents 4,287 restricted stock units, each of which represents a contingent right to receive one share of Common Stock. These restricted stock units vest in four equal annual installments beginning on July 22, 2016, such that 25% of the restricted stock units will vest on each of July 22, 2016, 2017, 2018 and 2019.
- F2These stock options vest in four equal annual installments beginning on July 22, 2016, such that 25% of the options will vest on each of July 22, 2016, 2017, 2018 and 2019.
- F3Each performance right represents a contingent right to receive one share of Common Stock. The target number of shares of Common Stock is set forth in columns 5 and 7 of Table II. Between 0% and 200% of the target number will be earned based on total shareholder return relative to a peer group of companies over a three-year performance period covering the Company's fiscal years 2016, 2017 and 2018. Any shares that do not vest at the end of the performance period will be forfeited.